Arconic Inc. (ARNC)
(Delayed Data from NYSE)
$22.41 USD
+0.50 (2.28%)
Updated May 3, 2019 04:01 PM ET
After-Market: $22.41 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.41 USD
+0.50 (2.28%)
Updated May 3, 2019 04:01 PM ET
After-Market: $22.41 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Arconic's (ARNC) Earnings Top Estimates in Q3, Revenues Lag
by Zacks Equity Research
Arconic (ARNC) gained from strong volumes across major markets and favorable pricing in Q3.
Arconic (ARNC) Beats Q3 Earnings Estimates
by Zacks Equity Research
Arconic (ARNC) delivered earnings and revenue surprises of 9.43% and -1.20%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Will Fosterville Aid Kirkland Lake Gold's (KL) Q3 Earnings?
by Zacks Equity Research
Higher gold production at Fosterville and increased gold prices are likely to get reflected in Kirkland Lake Gold's (KL) Q3 results.
Kinross (KGC) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Kinross (KGC) is likely to have benefited from higher production from its biggest operations in Q3.
Why Arconic (ARNC) Might Surprise This Earnings Season
by Zacks Equity Research
Arconic (ARNC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings.
Mining Stock Earnings Slated on Nov 5: NEM, ARNC, BTG, SSRM
by Anindya Barman
Let's take a look at how these mining companies are poised ahead of their earnings release.
Newmont Goldcorp (NEM) to Post Q3 Earnings: What's in Store?
by Nilanjan Gupta
Our proven model doesn't conclusively predict an earnings beat for Newmont Goldcorp (NEM) this time around.
What's in the Cards for Royal Gold's (RGLD) Q1 Earnings?
by Zacks Equity Research
Royal Gold's (RGLD) Q1 results likely to reflect benefits from investment in properties, higher average gold and silver prices, and positive results from Mount Milligan.
Arconic (ARNC) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Arconic (ARNC) is likely to have benefited from cost reduction and operational improvements actions and higher volumes across major end-markets in Q3.
Scotts Miracle-Gro to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sunlight Supply acquisition, higher promotional activities and increased retail support are likely to reflect in Scotts Miracle-Gro's (SMG) Q4 results.
Barrick (GOLD) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Our proven model doesn't conclusively predict an earnings beat for Barrick (GOLD) this time around.
The Market Timing Secrets No One Talks About - October 31, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Chemours (CC) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Our proven model does not conclusively predict that Chemours (CC) is likely to beat the Zacks Consensus Estimate this quarter.
Arconic (ARNC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arconic (ARNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DuPont (DD) Gears Up for Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Soft demand is expected to have impacted DuPont's (DD) organic sales in the third quarter.
U.S. Steel (X) Warms Up to Q3 Earnings: What's in Store?
by Zacks Equity Research
Our proven model does not conclusively predict that U.S. Steel (X) is likely to beat the Zacks Consensus Estimate in Q3.
FMC Corp (FMC) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Our proven model does not conclusively predict that FMC Corp (FMC) is likely to beat the Zacks Consensus Estimate in Q3.
Freeport-McMoRan (FCX) Looks Good: Stock Adds 6.6% in Session
by Zacks Equity Research
Freeport-McMoRan (FCX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
How to Time the Markets Like an Investing Pro - October 11, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
U.S. Steel (X) Updates Outlook for Q3, Trims Loss Guidance
by Zacks Equity Research
U.S. Steel''s (X) updated earnings view for Q3 is better than the underwhelming guidance it had issued in September.
Will Arconic (ARNC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Arconic (ARNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Should You Add Arconic (ARNC) Stock to Your Portfolio?
by Zacks Equity Research
Arconic (ARNC) is well placed to gain from strong growth across its key end-markets and operational improvement actions.
Agnico Eagle's Amaruq Deposit Attains Commercial Production
by Zacks Equity Research
The start of production at the Meliadine and Amaruq projects positions Agnico Eagle (AEM) to generate net free cash flow in second-half 2019.
Scotts Miracle-Gro Upsizes & Prices Senior Notes Due 2029
by Zacks Equity Research
Scotts Miracle-Gro (SMG) is expected to utilize the net proceeds from the offering to redeem all of its outstanding 6% senior notes due 2023.
Why You Should Keep Eastman Chemical (EMN) in Your Portfolio
by Zacks Equity Research
Eastman Chemical (EMN) should benefit from its cost management actions amid a difficult global business environment.